Similar Papers

Paper Title
Journal
Date
Author
Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation
Bartlomiej M Getta ... Mikhail Roshal
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | VOL. 23
Bartlomiej M Getta, et. al.Bartlomiej M Getta ... Mikhail Roshal
15 Mar 2017
Value of Pretransplantation Minimal Residual Disease in Acute Myeloid Leukemia and Myeloablative Hematopoietic Cell Transplantation.
Leyre Bento ... Jose Luis Diez-Martin
Blood | VOL. 120
Leyre Bento, et. al.Leyre Bento ... Jose Luis Diez-Martin
16 Nov 2012
Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.
Tim Grob ... Markus G Manz
Journal of Clinical Oncology | VOL. 41
Tim Grob, et. al.Tim Grob ... Markus G Manz
31 Oct 2022
The Prognostic Significance of Measurable ("Minimal") Residual Disease in Acute Myeloid Leukemia.
Francesco Buccisano ... Christopher S Hourigan
Current hematologic malignancy reports | VOL. 12
Francesco Buccisano, et. al.Francesco Buccisano ... Christopher S Hourigan
13 Oct 2017
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Brentuximab vedotin and nivolumab for cHL.
-
Blood | VOL. 145
--
16 Jan 2025
B-1 B cells lose self-control in SCD.
David R Gibb ... Sean R Stowell
Blood | VOL. 145
David R Gibb, et. al.David R Gibb ... Sean R Stowell
16 Jan 2025
Is it time to screen for multiple myeloma?
Irene M Ghobrial ... Floris Chabrun
Blood | VOL. 145
Irene M Ghobrial, et. al.Irene M Ghobrial ... Floris Chabrun
16 Jan 2025
Daratumumab for maintenance in myeloma.
Cyrille Touzeau ... Aurore Perrot
Blood | VOL. 145
Cyrille Touzeau, et. al.Cyrille Touzeau ... Aurore Perrot
16 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.